FDA Inspection 913210 — Mark C. Liu, M.D., Clinical Investigator
The FDA completed an inspection of Mark C. Liu, M.D., Clinical Investigator on Feb 4, 2015 in Baltimore, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 4, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Baltimore, MD (United States)
Additional Details
Clinical Investigator (CI)